secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalo Therapeutics, Inc. (AVTX)
CIK:        0001534120
Form:       8-K
Filed at:   2025-10-10T23:59:59+00:00
Accession:  0001534120-25-000011
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalo Therapeutics posts updated investor presentation; no material new data disclosed
--------------------------------------------------------------------------------

- Presentation dated October 2025 describes pipeline of novel IL-1β therapies.
- No new clinical data, financial results, or guidance changes included in update.
- Presentation used for routine investor meetings; no material events announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534120/000153412025000011/0001534120-25-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534120/000153412025000011/avtx-20251010.htm
  HTML page:      https://secwatch.observer/filing/0001534120-25-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer